On the uptake of cationic liposomes by cells: from changes in elasticity to internalization

In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cells. We used atomic force microscopy to observe phy...

ver descrição completa

Detalhes bibliográficos
Autores: Botet Carreras, Adrià, Bosch Marimon, Manel, Millán Solsona, Rubén, Aubets Gil, Eva, Ciudad i Gómez, Carlos Julián, Noé Mata, Verónica, Montero, M.Teresa, Domènech Cabrera, Òscar, Borrell Hernández, Jordi
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/198462
Acesso em linha:https://hdl.handle.net/2445/198462
Access Level:acceso abierto
Palavra-chave:Liposomes
Sistemes d'alliberament de medicaments
Microscòpia de força atòmica
Drug delivery systems
Atomic force microscopy
Descrição
Resumo:In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cells. We used atomic force microscopy to observe physicochemical changes on the cell surface and confocal microscopy to determine how the liposomes interact with cell membranes and released their load. In addition, we performed viability assays using methotrexate as an active drug to obtain proof of concept of the formulation´s capacity to function as a drug delivery-system. The interaction of engineered liposomes with living cells corroborates the information obtained using model membranes and supports the capacity of the engineered liposomal formulation to serve as a potential nanocarrier.